Karel Van De Sompel, country manager of Pfizer in Belgium and Luxembourg and chairman of Pharma.be, highlights the key changes he sees in today’s pharma market which revolve around the increasing trend of personalized medicine, digitalization, big healthcare data, and stakeholder partnerships. Additionally, Van De Sompel also elaborates on Pfizer’s strategic positioning within the country’s healthcare ecosystem and the significance that Belgium holds for the company’s global operations.
We are proud of the fact that 68 years ago Pfizer decided to set up its first affiliate outside of the US here in Belgium. Since then, our footprint has increased dramatically
